UI Hospitals and Clinics
A Phase II Study of the Angiopoietin-1 and -2 Peptibody AMG 386 for the Treatment of Angiosarcoma
Participants in this research study have been diagnosed with angiosarcoma that is unable to be removed by surgery. The purpose of this research study is to find out what effects, good and/or bad, an experimental drug called AMG 386 has on the angiosarcoma. Approximately 5 people will take part in this study conducted by investigators at the University of Iowa. About 41 subjects will take part in this study nationwide. Study treatment will last as long as it is helping the cancer.
Clarine Halvorsen, 319-356-3944
We welcome your feedback! Please help us improve your experience on our website by completing a brief survey.